MEIRAGTX HOLDINGS PLC (MGTX)
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
TSMC Files Annual Report on Form 20-F for 2025
Vipshop Filed 2025 Annual Report on Form 20-F
Edwards Lifesciences Corp - Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
Bilibili Publishes 2025 Environmental, Social and Governance Report
Dormant shares – change in the number of shares